KOCAA
HAE icon

Knights of Columbus Asset Advisors’s Haemonetics HAE Stock Holding History

Knights of Columbus Asset Advisors’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-21,168
Closed -$1.75M – 420
2024
Q2 		$1.75M Sell
21,168
-19,171
-48% -$1.69M 0.11% 221
2024
Q1 		$3.44M Sell
40,339
-4,222
-9% -$331K 0.25% 143
2023
Q4 		$3.81M Buy
44,561
+34,556
+345% +$2.99M 0.25% 182
2023
Q3 		$896K Buy
10,005
+128
+1% +$11.4K 0.08% 244
2023
Q2 		$841K Hold
9,877
– – 0.08% 253
2023
Q1 		$817K Buy
+9,877
New +$800K 0.08% 245
2020
Q2 		– Sell
-19,015
Closed -$1.9M – 360
2020
Q1 		$1.9M Buy
+19,015
New +$2.06M 0.24% 130

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Knights of Columbus Asset Advisors's HAE Position: Q3 2024 in Review

Knights of Columbus Asset Advisors sold out of Haemonetics (HAE) in Q3 2024, closing a stake of 21,168 shares — an estimated $1.75M sold.

Knights of Columbus Asset Advisors first reported a position in HAE in Q1 2020 and held it in 7 quarters. The position peaked at $3.81M in Q4 2023. 306 funds tracked by Wall St. Rank hold HAE as of Q3 2024.

  • Knights of Columbus Asset Advisors reported no remaining Haemonetics position as of Q3 2024 after selling out during the quarter.
  • Knights of Columbus Asset Advisors sold 21,168 Haemonetics shares in Q3 2024, an estimated $1.75M.
  • Knights of Columbus Asset Advisors first reported a position in Haemonetics in Q1 2020 and held it in 7 quarters.
  • Knights of Columbus Asset Advisors's Haemonetics position peaked at $3.81M in Q4 2023.
  • 306 funds tracked by Wall St. Rank held Haemonetics as of Q3 2024.

Based on Knights of Columbus Asset Advisors's 13F filing for Q3 2024, filed 12 Nov 2024.